Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae in southwestern Japan and correlation of penicillin-binding protein 2b and 2x mutations in susceptibilities of penicillin G and cefotaxime

Diagnostic Microbiology and Infectious Disease

Volumn 37, Issue 2, 2000, Pages 107-113

  Nagai, Kensuke ^a   Matsuo, Yusaku ^a   Tsumura, Naoki ^a   Sakata, Yasutaka ^a   Kato, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFACLOR; CEFDITOREN; CEFIXIME; CEFOTAXIME; CEFPIROME; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; MEROPENEM; PANIPENEM; PENICILLIN BINDING PROTEIN; PENICILLIN G; RIFAMPICIN; ROKITAMYCIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; BLOOD CULTURE; CEREBROSPINAL FLUID; CHILD; DILUTION; GENETIC ANALYSIS; HUMAN; IN VITRO STUDY; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MUTATION; OTITIS MEDIA; PEDIATRIC HOSPITAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROTYPE; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIAE;

AMINOACYLTRANSFERASES; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; CEFOTAXIME; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; HEXOSYLTRANSFERASES; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MICROBIAL SENSITIVITY TESTS; MURAMOYLPENTAPEPTIDE CARBOXYPEPTIDASE; MUTATION; PENICILLIN G; PENICILLIN RESISTANCE; PENICILLIN-BINDING PROTEINS; PENICILLINS; PEPTIDYL TRANSFERASES; PNEUMOCOCCAL INFECTIONS; POLYMERASE CHAIN REACTION; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0034077504     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(00)00127-9     Document Type: Article

References (29)

1. Appelbaum P.C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 15:1992;77-83.
2. Bradley J.S., Conor J.D. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced sensitivity to β-lactam antibiotics. Pediatr Infect Dis J. 10:1991;871-872.
3. Bradley J. S., Kaplan S. L., Klugman M. B., Leggiadro R. J. (1995). Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J, 14, 1037-1041.
4. Coffey T. J., Daniels M., McDougal L. K., Dowson C. G., Tenover F. C., Spratt G. B. (1995). Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins. Antimicrob Agents Chemother 39, 1306-1313.
5. Dowson C. G., Hutchison A., Spratt B. G. (1989). Extensive re-modeling of the transpeptidase domain of penicillin-binding protein 2B of a penicillin-resistant South African isolate of Streptococcus pneumoniae. Mol Microbil, 3, 95-102.
6. Friedland I. R., Paris M., Ehrett S., Hickey S., Olsen K., McCracken G. H., Jr (1993). Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 37, 1630-1636.
7. Hakenbeck R. (1999). β-Lactam-resistant Streptococcus pneumoniae: epidemiology and evolutionary mechanism. Chemotherapy 45, 83-94.
8. Jacobs M. R. (1996). Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J 15, 940-943.
9. Jacobs M. R., Bajaksouzian S., Zilles A., Lin G., Pankuch G. A., Appelbaum P. C. (1998). Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob Agents Chemother 43, 1901-1908.
10. Klugman K. P., Dagan R. (1995). Carbapenem treatment of meningitis. Scand J Infect Dis 96(suppl.) 45-48.
11. Laible G., Hakenbeck R., Sicard M. A., Joris B., Ghuysen J-M. (1989). Nucleotide sequence of the pbpx genes encoding the penicillin-binding proteins 2x from Streptococcus pneumoniae R6 and a cefotaxime-resistant mutant, C506. Mol Microbiol 3, 1337-1348.
12. McCracken G. H. Jr, Nelson J. D., Kaplan S. L., Over G. D., Rodriguez W. J., Steele R. W. (1987). Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr Infect Dis J 6, 501-505.
13. McCracken G. H. Jr (1996). Introduction. Pediatr Infect Dis J 15, 930-931.
14. Motohiro T., Handa S., Yamada S., Oki S., Yoshinaga Y., Sasaki H., Aramaki M., Oda K., Sakata Y., Kato H. (1994). Basic and clinical studies on cefditoren pivoxil in pediatric field. Jpn J Antibiot 47, 409-427.
15. Nagai K., Shimizu T., Togo A., Takeya M., Yokomizo Y., Sakata Y., Matsuishi T., Kao H. (1997). Decrease in serum levels of valproic acid during treatment with a new carbapenem, panipenem/betamipron. J Antimicrob Chemother 39, 295-296.
16. National Committee for Clinical Laboratory Standards (1998). Performance standards for antimicrobial susceptibility testing, 8th informational supplement. M100-S8. Villanova, PA: NCCLS.
17. París M. M., Ramilo O., McCracken G. H. Jr (1995). Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 39, 2171-2175.
18. Pankuch G. A., Visalli M. A., Jacobs M. R., Appelbaum P. C. (1998). Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 (RU 66647), a new ketolide, compared with susceptibilities to 17 other agents. Antimicrob Agents Chemother 42, 624-630.
19. Shimada K. (1994). New antimicrobial agent series XLVI: panipenem/betamipron. Jpn J Antibiot 47, 219-244.
20. Solas M., Barret F., Chesney J., English B. K., Hill B. C., Tenover F. C., Leggiadro R. J. (1992). Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 11, 662-666.
21. Song J. H., Lee N. Y., Ichiyama S., Yoshida R., Hirakata Y., Fu W., Chongthaleong A., Aswapokee N., Chiu C. H., Lalitha M. K., Thomas K., Perera J., Yee T. T., Jamal F., Warsa U. C., Vinh B. X., Jacobs M. R., Appelbaum P. C., Pai C. H. (1999). Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Clin Infect Dis 28, 1206-1211.
22. Spangler S. K., Jacobs M. R., Appelbaum P. C. (1994). Susceptibilities of 177 penicillin-susceptible and - resistant pneumococci to FK037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob Agents Chemother 38, 898-900.
23. Spangler S. K., Jacobs M. R., Appelbaum P. C. (1997). MIC and time-kill studies of antipneumococcal activity of GV 118819X (Sanfetrinem) compared with those of other agents. Antimicrob Agents Chemother 41, 148-155.
24. Sugita R., Deguchi K., Kimura S., Harada S., Fujimaki Y., Watanabe H., Naito M., Nomura T., Tanaka M., Komatsu N., Shimizu K., Yoshida Y., Okano K. (1996). Efficacy of cefditoren pivoxil in the treatment of acute otitis media due to benzylpenicillin-insensitive Streptococcus pneumoniae. Jpn J Antibiot 49, 386-398.
25. Tomasz A. (1999). New faces of an old pathogen: emergence and spread of multidrug-resistant Streptococcus pneumoniae. Am J Med 107(1A), 55s-62s.
26. Ubukata K., Asahi Y., Yamane A., Konno M. (1996). Combinational detection of autolysin and penicillin-binding protein 2B genes of Streptococcus pneumoniae by PCR. J Clin Microbiol 34, 592-596.
27. Viladrich P. F., Gudiol F., Linares J., Pallares R., Sabate I., Rufi G., Ariza J. (1991). Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 35, 2467-2472.
28. Wolff M., Chavanet P., Kazmierczak A., Pechinot A., Dematons C., Portier H., Lenfant B. (1992). Diffusion of cefpirome into the cerebrospinal fluid of patients with purulent meningitis. J Antimicrob Chemother 29, Suppl A, 59-62.
29. Yamane A., Nakano H., Asahi Y., Ubukata K., Konno M. (1996). Directly repeated insertion of 9-nucleotide sequence detected in penicillin-binding protein 2B gene of penicillin-resistant Streptococcus pneumoniae. J Clin Microbiol 40, 1257-1259.